[Etiology and specific diagnosis of infectious-allergic bronchial asthma]. 1968

A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas
D012882 Skin Tests Epicutaneous or intradermal application of a sensitizer for demonstration of either delayed or immediate hypersensitivity. Used in diagnosis of hypersensitivity or as a test for cellular immunity. Skin Test,Test, Skin,Tests, Skin
D014612 Vaccines Suspensions of killed or attenuated microorganisms (bacteria, viruses, fungi, protozoa), antigenic proteins, synthetic constructs, or other bio-molecular derivatives, administered for the prevention, amelioration, or treatment of infectious and other diseases. Vaccine

Related Publications

A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
March 1988, Klinicheskaia meditsina,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
September 1969, Minnesota medicine,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
January 1976, Terapevticheskii arkhiv,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
January 1980, Allergologia et immunopathologia,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
November 1949, University of Western Ontario medical journal,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
August 1986, Klinicheskaia meditsina,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
August 1981, Revista medica de Chile,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
February 1972, Vrachebnoe delo,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
May 1968, Terapevticheskii arkhiv,
A D Ado, and N V Adrianova, and V P Dovzhik, and V N Fedoseeva
January 1987, Sovetskaia meditsina,
Copied contents to your clipboard!